Pharma Major-Sanofi India Reports 8 Per Cent Growth in Q4 2024 Net Sales Amid Strategic Demerger Pharma Major-Sanofi India Reports 8 Per Cent Growth in Q4 2024 Net Sales Amid Strategic Demerger Total revenue from operations for the full year 2024 was Rs 2,013.2 crore, showing a slight increase from Rs 1,996.1 crore in 2023. Kiran Shroff / Friday, February 28, 2025 0 63 Article rating: 5.0 The company has maintained a final dividend of Rs 117 per equity share, subject to shareholder approval. Read more